Knobbe Martens

Contact
Share
Info
2040 Main Street
14th Floor
Irvine, CA 92614, United States
Phone: (949) 760-0404
Fax: (949) 760-9502
Areas of Practice
  • Intellectual Property
  • Litigation
Locations
Other U.S. Locations
  • California
  • D.C.
  • New York
  • Washington
Number of Attorneys
100+ Attorneys

Diabetes Monitoring Technology Moving Toward Consumer Convenience

The FDA recently approved Abott’s FreeStyle Libre Flash Glucose Monitoring System. According to Bloomberg, this device marks the first continuous glucose monitoring system that adults can use that does not use diagnosis via…more
 /  Health, Science, Computers, & Technology

FDA Provides Guidance on 3D-Printed Medical Device Products

The U.S. Food and Drug Administration released finalized guidance regarding 3D printing in medical devices. The guidance document, which issued on December 5, 2017, is based on the FDA’s review of more than 100 devices currently…more
 /  Health, Science, Computers, & Technology

FDA Clears First Apple Watch Medical Device Accessory

The FDA recently cleared the first medical device accessory for the Apple Watch — AliveCor’s KardiaBand. According to AliveCor, the Kardiaband is a mobile, real-time electrocardiogram (EKG) reader that can record an EKG within…more
 /  Health, Science, Computers, & Technology

Inventor Holdings, Llc V. Bed Bath & Beyond, Inc.

Federal Circuit Summaries - Before Wallach, Chen, and Stoll. Appeal from the United States District Court for the District of Delaware. Summary: Even if a patentee’s initial complaint was reasonable, the patentee can be…more
 /  Civil Procedure, Civil Remedies, Intellectual Property

Federal Circuit Review - November 2017

Fractured Federal Circuit Holds Patent Owner Does Not Bear Burden of Persuasion in IPR Motions to Amend - In Aqua Products, Inc. v. Matal, Appeal No. 2015-1177, the Federal Circuit, sitting en banc, held that a patent owner…more
 /  Administrative Law, Civil Procedure, Intellectual Property, Science, Computers, & Technology

Pfizer Accuses J&J of Anticompetitive Business Practices over Remicade Biosimilar

In a recent development with the ongoing complex litigation involving Janssen Biotech’s arthritis biologic medicine Remicade (infliximab) and Celltrion’s biosimilar, Celltrion’s partner Pfizer has filed a suit against Janssen’s…more
 /  Antitrust & Trade Regulation, Commercial Law & Contracts, Health, Science, Computers, & Technology

PTAB Issues New Remand Procedures

On November 16, 2017, the USPTO issued new procedures (“Standard Operating Procedure 9”) for governing cases remanded from the Federal Circuit. These procedures are applicable to all decisions remanded from the Federal Circuit…more
 /  Administrative Law, Intellectual Property

Sanofi, Sanofi-Aventis U.S., LLC V. Watson Labs. Inc., Sandoz, Inc.

Federal Circuit Summaries - Before PROST, WALLACH, and TARANTO.  Appeal from the District of Delaware Summary: (1) A party may not avoid inducement based on “substantial non-infringing uses,” and (2) prosecution history…more
 /  Civil Procedure, Intellectual Property, Science, Computers, & Technology

FDA Approves Zelboraf for Treatment of a Rare Cancer

On November 6th, 2017, the U.S. Food and Drug Administration (FDA) approved the drug Zelboraf (vemurafenib), for the treatment of Erdheim-Chester Disease (ECD). The FDA approved Zelboraf under Priority Review, Breakthrough…more
 /  Health, Science, Computers, & Technology

USPTO to increase IPR fees by 33% and PGR fees by 27% in 2018

The USPTO announced that the official fees for IPR and PGR will increase significantly starting on January 16, 2018. See 82 Fed. Reg. 52780, 52807 (Nov. 14, 2017)…more
 /  Administrative Law, Intellectual Property

Federal Circuit Review - October 2017

Federal Circuit Denies En Banc Rehearing in Mentor Graphics v. EVE-USA - In Mentor Graphics Corp. v. Eve-USA, Inc., Appeal Nos. 2015-1470, 2015-1554, 2015-1556, the Federal Circuit denied Synopsys’ and EVE’s petition for en…more
 /  Alternative Dispute Resolution (ADR), Civil Procedure, Civil Remedies, Constitutional Law, Intellectual Property

Searching for How: The Federal Circuit’s Continued Quest under Alice

On October 16, 2017, the Federal Circuit affirmed the district court’s ruling that the claims in Secured Mail Solutions LLC, v. Universal Wilde, Inc. (“Secured Mail”) were directed to patent-ineligible subject matter under 35…more
 /  Intellectual Property, Science, Computers, & Technology

Amicus Curiae Briefs Authorized on Tribal Sovereign Immunity in IPRs of Restasis® Patents

The Saint Regis Mohawk Tribe’s recent motion to terminate pending IPRs on patents purported to cover Allergan’s Restasis® product has spurred two parties to seek authorization from the PTAB to file amicus briefs. Earlier this…more
 /  Administrative Law, Indigenous Peoples, Intellectual Property, Science, Computers, & Technology

Is it Pretty? Will H&M Assert a “Classixx” Ornamental Defense to Claims of Trademark Infringement?

On October 19, 2017 Hush Hush Sound Inc, Michael David, and Tyler Blake (collectively “Plaintiffs”) also known as the Electronic dance music duo “Classixx” filed suit in the District Court for the Central District of California…more
 /  Communications & Media Law, Intellectual Property

Unlicensed Use of a Festival Name May Result in a Not-So-Festive Trademark Lawsuit

Music festivals, film festivals, food festivals….festivals are popular venues for entertainment and each festival strives to offer the consumer a unique experience. Of course, at most festivals, clothes must be (or should be)…more
 /  Civil Remedies, Commercial Law & Contracts, Communications & Media Law, Intellectual Property
Showing 1-15 of 762 Results
/
View per page
Page: of 51
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.